Sat.Aug 03, 2024 - Fri.Aug 09, 2024

article thumbnail

Greenland fossil discovery reveals increased risk of sea-level catastrophe

Science Daily: Pharmacology News

Seeds, twigs, and insect parts found under two miles of ice confirm Greenland's ice sheet melted in the recent past, the first direct evidence that the center -- not just the edges -- of the two-mile-deep ice melted away in the recent geological past. The new research indicates that the giant ice sheet is more fragile than scientists had realized until the last few years -- and reveals increased risk of sea-level catastrophe in a warmer future.

Research 145
article thumbnail

Roche licenses Sangamo’s technology for another shot at Alzheimer’s drugs

BioPharma Drive: Drug Pricing

Through a new deal, Roche has exclusive rights to Sangamo molecules designed to repress the gene that makes “tau,” a protein many scientists view as a main driver of Alzheimer’s.

Licensing 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Lenacapavir Exhibits Atropisomerism - Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance Pathway [Metabolism, Transport, and Pharmacogenetics]

ASPET

Lenacapavir (LEN), a long-acting injectable, is the first approved human immunodeficiency virus type 1 capsid inhibitor and one of a few FDA-approved drugs that exhibit atropisomerism. LEN exists as a mixture of two class 2 atropisomers that interconvert at a fast rate (t 1/2 <2 hours) with a ratio that is stable over time and unaffected by enzymes or binding to proteins in plasma.

article thumbnail

Exploring the potential of ADCs beyond oncology

Drug Target Review

What are the main therapeutic areas beyond oncology where ADCs show potential? A number of areas represent significant opportunities for Antibody Drug Conjugates (ADCs) beyond oncology, leveraging their ability to deliver therapeutic agents specifically to diseased cells or tissues while minimising off-target effects. The development of ADCs in these areas is ongoing, with several preclinical and clinical studies exploring their potential.

Therapies 117
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Record-breaking recovery of rocks that originated in Earth's mantle could reveal secrets of planet's history

Science Daily: Pharmacology News

Scientists have recovered the first long section of rocks that originated in the Earth's mantle, the layer below the crust and the planet's largest component. The rocks will help unravel the mantle's role in the origins of life on Earth, the volcanic activity generated when it melts, and how it drives the global cycles of important elements such as carbon and hydrogen.

143
143
article thumbnail

In tone-setting verdict, FDA rejects MDMA as a therapy aid for PTSD

BioPharma Drive: Drug Pricing

The decision to turn down an application from Lykos Therapeutics comes at a pivotal time for psychedelics research, which, after decades of dismissal, has recently gained momentum.

Therapies 130

More Trending

article thumbnail

More Evidence That an Artificial Sweetener Poses Heart Risk

Drugs.com

THURSDAY, Aug. 8, 2024 -- There's more evidence to suggest that the common artificial sweetener erythritol might pose dangers to consumers' hearts.The new study, involving 20 healthy adult volunteers, found that at doses commonly found in an.

116
116
article thumbnail

Bacteria encode hidden genes outside their genome--do we?

Science Daily: Pharmacology News

A 'loopy' discovery in bacteria is raising fundamental questions about the makeup of our own genome -- and revealing a potential wellspring of material for new genetic therapies.

Therapies 141
article thumbnail

With pharma in ‘catbird seat,’ biotechs get less upfront in drug partnerships

BioPharma Drive: Drug Pricing

Recent data from J.P. Morgan indicates early-stage startups are getting smaller upfront payments in alliances than a few years ago, a trend industry insiders attribute to weaker leverage in deal talks.

Drugs 131
article thumbnail

Regulation of cannabinoid and opioid receptor levels by endogenous and pharmacological chaperones [Cellular and Molecular]

ASPET

Cannabinoid and opioid receptor activities can be modulated by a variety of posttranslational mechanisms including the formation of interacting complexes. This study examines the involvement of endogenous and exogenous chaperones in modulating the abundance and activity of cannabinoid CB 1 receptor (CB 1 R), delta opioid receptor (DOR), and CB 1 R-DOR interacting complexes.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Childhood Vaccines Have Saved 1 Million U.S. Lives Since 1994, CDC Says

Drugs.com

FRIDAY, Aug. 9, 2024 -- In findings that offer compelling evidence of the power of childhood vaccines, a new government report shows the routine shots have prevented hundreds of millions of illnesses, tens of millions of hospitalizations and more.

Vaccine 111
article thumbnail

Smallest arm bone in human fossil record sheds light on the dawn of Homo floresiensis

Science Daily: Pharmacology News

A new study reports the discovery of extremely rare early human fossils from the Indonesian island of Flores, including an astonishingly small adult limb bone. Dated to about 700,000 years old, the new findings shed light on the evolution of Homo floresiensis, the so-called 'Hobbits' of Flores whose remains were uncovered in 2003 at Liang Bua cave in the island's west.

141
141
article thumbnail

Biotech Red Queen launches with $55M to build versatile antivirals

BioPharma Drive: Drug Pricing

The funding from Apple Tree Partners will help the startup advance an antiviral drug pipeline that includes a COVID treatment nearing mid-stage testing.

Treatment 133
article thumbnail

Unlocking the Power of Azure Integration Services for the Financial Services Industry

Perficient: Drug Development

In today’s rapidly evolving digital landscape, financial services organizations are increasingly relying on cutting-edge technologies to stay competitive and deliver exceptional services to their clients. Microsoft’s Azure Integration Services , a suite of tools designed to seamlessly connect applications, data, and processes, is emerging as a game-changer for the financial services industry.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Many Doctors Underestimate the Pain of IUD Insertion for Women. The CDC Wants to Change That

Drugs.com

THURSDAY, Aug. 8, 2024 -- Plenty of women know that having an IUD inserted in their uterus can be an excruciating experience, but new government guidance issued Thursday may soon make the experience less painful for many.For the first time, updated.

Doctors 111
article thumbnail

3D-printed blood vessels bring artificial organs closer to reality

Science Daily: Pharmacology News

Lab-grown organs are a long-time 'holy grail' of organ engineering that has yet to be achieved, but new research has brought that goal a big step closer to reality using a new 3D-printing method called co-SWIFT. co-SWIFT prints branching networks of double-layered vessels that are infused with smooth muscle cells and endothelial cells into living human cardiac tissue, and can even replicate patient-specific vascular structures,indicating that it could one day be used for personalized medicine.

article thumbnail

Lilly boosts outlook on rising Zepbound revenue

BioPharma Drive: Drug Pricing

Sales of the in-demand obesity drug crested $1 billion in the second quarter as improved Lilly production helped the company fulfill wholesaler backorders.

article thumbnail

Leveraging Automation to Streamline Clinical Data Management

Quanticate

The clinical trials industry is changing rapidly to move with today's technological advancements and at the front of this exciting movement is the adoption of AI (Artificial Intelligence) and ML (Machine Learning). Our industry has successfully incorporated both innovations to help push the boundaries of medical research and increase its effectiveness and efficiency through using these tools to help streamline and automate critical processes, which previously would have taken far longer to compl

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Botanicals Like Turmeric, Green Tea Are Harming Americans' Livers

Drugs.com

MONDAY, Aug. 5, 2024 -- Botanicals like turmeric, green tea and black cohosh may seem benign, but their overuse is being increasingly linked to liver injury. New research suggests that 7% of U.S. adults are using at least one of the six leading.

Research 111
article thumbnail

Scientists lay out revolutionary method to warm Mars

Science Daily: Pharmacology News

Ever since we learned that the surface of planet Mars is cold and dead, people have wondered if there is a way to make it friendlier to life. The newly proposed method is over 5,000 times more efficient than previous schemes to globally warm Mars, representing a significant leap forward in our ability to modify the Martian environment.

136
136
article thumbnail

Zepbound shortages ease, but Lilly cautions pharmacy availability may remain ‘choppy’

BioPharma Drive: Drug Pricing

After months of supply strains, Lilly has begun to catch up with demand. Consumers may still need to wait for their prescriptions to be filled, however.

Pharmacy 122
article thumbnail

Understanding Microservices Architecture: Benefits and Challenges Explained

Perficient: Drug Development

Understanding Microservices Architecture: Benefits and Challenges Explained Microservices architecture is a transformative approach in backend development that has gained immense popularity in recent years. To fully grasp the advantages of microservices, it is essential first to understand monolithic architecture, as microservices emerged primarily to address its limitations.

article thumbnail

Heavy Marijuana Use More Than Triples Odds for Head & Neck Cancers

Drugs.com

THURSDAY, Aug. 8, 2024 -- People who use marijuana at high levels are putting themselves at more than three times the risk for head and neck cancers, new research warns.The study is perhaps the most rigorous ever conducted on the issue, tracking.

Research 111
article thumbnail

Cracking the code of life: new AI model learns DNA's hidden language

Science Daily: Pharmacology News

With GROVER, a new large language model trained on human DNA, researchers could now attempt to decode the complex information hidden in our genome. GROVER treats human DNA as a text, learning its rules and context to draw functional information about the DNA sequences.

DNA 132
article thumbnail

Novo shares tumble on lower-than-expected obesity drug sales

BioPharma Drive: Drug Pricing

Quarterly revenue from Ozempic and Wegovy missed Wall Street estimates by about 9%, concerning some analysts and causing a stock sell-off costing the Danish drugmaker tens of billions in market value.

Marketing 112
article thumbnail

Shifting Paradigms in PAH Clinical Trials: 7 Key Takeaways for Success

PPD

Pulmonary arterial hypertension (PAH) is a progressive and fatal lung disease that is caused or influenced by multiple factors. Historically, the available drugs and U.S. Food and Drug Administration (FDA)-approved therapies for treating PAH were primarily vasodilators, designed to overcome the imbalance between vasoactive and vasodilator mediators and to restore endothelial cell function.

article thumbnail

Cost Keeps Many Who Need Them From Getting New Weight-Loss Meds

Drugs.com

WEDNESDAY, Aug. 7, 2024 (HealthDay news) -- Medicare and Medicaid patients are less likely to get cutting-edge weight-loss drugs than people with private insurance are, a new study finds.Medicaid accounted for less than 10% of semaglutide (Ozempic.

Drugs 111
article thumbnail

Scientists and climate change: Extreme concern and high level of engagement

Science Daily: Pharmacology News

Scientists from across academic disciplines are extremely concerned about climate change. Many of them have already changed their own lifestyles or engaged in advocacy and protest, with even more being willing to do so in future. This is evident from a large-scale survey of scientists from all over the world.

133
133
article thumbnail

Amgen talks obesity drug ‘differentiation’; Servier brain cancer drug approved by FDA

BioPharma Drive: Drug Pricing

Executives at Amgen had few updates on their drug MariTide, but defended what they see as the once-monthly shot’s competitive profile.

FDA 124
article thumbnail

Merken Biotech Adopts CDD Vault for Advanced Drug Discovery Services

Collaborative Drug

Santiago, Chile – August 6, 2024—Merken Biotech, a leading research service company in biotechnology, proudly announces the adoption of CDD Vault, a premier informatics platform by Collaborative Drug Discovery (CDD). This strategic move will enhance Merken Biotech’s service capabilities, streamlining data management and accelerating drug discovery processes for its clients.

Drugs 92
article thumbnail

Fish Oil Might Help Keep Cholesterol in Check

Drugs.com

THURSDAY, Aug. 8, 2024 -- People with a genetic predisposition for high cholesterol can lower their levels by taking fish oil supplements, a new study shows.The results indicate that lifestyle can be a powerful influence on artery-clogging.

105
105
article thumbnail

Processing traumatic memories during sleep leads to changes in the brain associated with improvement in PTSD symptoms

Science Daily: Pharmacology News

Currently, the first-choice treatment for PTSD is exposure-based psychotherapy, where therapists help rewire the emotions associated with the traumatic memory in the patient's brain, shifting from fear and arousal to a more neutral response. However, up to 50% of patients fail to respond well to this treatment. In a new study scientists showed for the first time that reactivating therapeutically-altered memories during sleep leads to more brain activity related to memory processing, which is ass

Treatment 127
article thumbnail

Merck bets $700M on an antibody drug’s potential in immune diseases

BioPharma Drive: Drug Pricing

The deal hands Merck a cancer medicine already in human testing, but that the company sees as a potential treatment for autoimmune conditions, too.

Disease 119